Oncozine.com - SEO Check

Jetzt kostenlos registrieren! PDF Export
Übersicht der SEO Analyse
Metaangaben
80% 
Seitenqualität
64% 
Seitenstruktur
58% 
Verlinkung
0% 
Server
86% 
Externe Faktoren
100% 
SEO Score
Antwortzeit
1,01 s
Dateigröße
221,30 kB
Wörter
1884
Medien
8
Anzahl Links
283 Intern / 75 Extern

To-do Liste mit SEO Optimierungen

Meta-Angaben im HTML

Titel
(Extrem wichtig)
Home - Onco'Zine - A part of the Oncology and Hematology News Network
Der Titel sollte kürzer als 580 Pixel sein. Er ist insgesamt 670 Pixel lang. Jetzt optimieren
Es gibt keine Wortwiederholungen im Titel.
Meta-Description
(Extrem wichtig)
Onco'Zine is part of the Oncology and Hematology News Network that has been created to better inform physicians treating patients with cancer
Die Meta-Description hat eine optimale Länge. (887 Pixel von maximal 1000 Pixel Länge)
Crawlbarkeit
(Extrem wichtig)
Es gibt keine Probleme beim Zugriff auf die Webseite.
Canonical Link
(Wichtig)
https://www.oncozine.com/
Die Seite hat einen korrekten Canonical Link.
Sprache
(Wenig wichtig)
Im Text erkannte Sprache: en
Im HTML angegebene Sprache: en-us
Serverstandort: Vereinigte Staaten von Amerika
Die Sprache wird im HTML Code wie folgt angegeben: en-us
Alternate/Hreflang Links
(Wenig wichtig)
Die Seite nutzt keine Alternate Links.
Weitere Metatags
(Wenig wichtig)
Es gibt keinen rel next Meta Tag auf der Seite.
Es gibt keinen rel prev Meta Tag auf der Seite.
Domain
(Wenig wichtig)
Die Domain ist keine Subdomain.
Die Länge der Domain ist gut.
Die Domain enthält keine Umlaute.
Seiten URL
(Wenig wichtig)
In der URL wurden keine Parameter entdeckt.
In der URL wurde keine Session ID entdeckt.
Die URL hat nicht zu viele Unterverzeichnisse.
Zeichensatzkodierung
(Wenig wichtig)
Die Angaben zur Zeichensatzkodierung (UTF-8) sind fehlerfrei.
Doctype
(Nice to have)
Die Doctype Angabe HTML 5 ist korrekt angegeben.
Die Doctype Angabe befindet sich an erster Stelle im HTML-Code.
Favicon
(Nice to have)
Das Favoriten Icon (Favicon) ist korrekt verlinkt.

Meta Tags

NameWert
viewportwidth=device-width, initial-scale=1.0
robotsindex, follow, max-image-preview:large, max-snippet:-1, max-video-preview:-1
descriptionOnco'Zine is part of the Oncology and Hematology News Network that has been created to better inform physicians treating patients with cancer
msvalidate.01325DBF0B4415B7D5F77949B32086EEB2
google-site-verificationDvS50_-wX_jjHKRtegP7b3R6lPTOcwGV7N7mm1J2oAk
generatorWordPress 6.5.5
msapplication-TileImagehttps://www.oncozine.com/wp-content/uploads/2018/09/cropped-circle-270x270.png
article:publisherhttps://www.facebook.com/oncozine.journal
article:modified_time2023-11-14T01:28:40+00:00
langen-us
twitter:cardsummary_large_image
twitter:site@OncoZine
fb:pageshttps://www.facebook.com/OncoZine/
og:localeen_US
og:typewebsite
og:titleHome - Onco'Zine - A part of the Oncology and Hematology News Network
og:descriptionOnco'Zine is part of the Oncology and Hematology News Network that has been created to better inform physicians treating patients with cancer
og:urlhttps://www.oncozine.com/
og:site_nameOnco'Zine
charsetUTF-8

Analysiere jetzt kostenlos bis zu 1.000 Unterseiten von oncozine.com!

Kostenlos Testen
Die Nutzung des Basis Accounts ist zeitlich unbegrenzt möglich

Seitenqualität

Inhalt
(Extrem wichtig)
Einige Wörter aus dem Seitentitel werden nicht im Text bzw. Inhalt der Seite verwendet
Es wurden nur 1 Fließtextblöcke auf der Seite gefunden.
Auf der Seite wurden Tippfehler entdeckt:
  • advertisment => advertisement
Der Inhalt ist mit 1884 Wörtern in Ordnung.
Der Text besteht zu 24.3% aus Füllwörtern.
Wörter aus der H1 Überschrift werden im Text der Seite verwendet.
Im Text befindet sich eine Aufzählung, dies deutet auf eine gute Textstruktur hin.
Es wurden keine Platzhalter Texte bzw. Bilder gefunden.
Es befinden sich keine Duplikate auf der Seite.
Die durchschnittliche Satzlänge ist mit 21 Wörtern gut.
Frames
(Extrem wichtig)
Die Seite hat kein Frameset.
Mobile
(Wenig wichtig)
Der angegebene Viewport (width=device-width, initial-scale=1.0) ist korrekt.
Mindestens ein Apple-Touch Icon ist definiert.
Bold- und Strongtags
(Wenig wichtig)
Die Nutzung von Strong- und Bold-Tags ist optimal. Wir empfehlen für diese Webseite die Verwendung von bis zu 38 Tags.
Bilder Optimierung
(Wenig wichtig)
Bei 1 Bildern fehlt das Alt-Attribut. Der Inhalt von Alt-Attributen wird von Suchmaschinen auch als Text gewertet und ist wichtig für die Bildersuche.
Soziale Vernetzung
(Nice to have)
Es befinden sich wenige Social-Sharing Möglichkeiten auf der Seite. Mit Plugins zum Teilen kann die Reichweite der Seite in sozialen Netzwerken erhöht werden.
Zusätzliches Markup
(Nice to have)
Es wurde kein zusätzliches Markup gefunden.
HTTPS
(Wenig wichtig)
Die Seite verwendet HTTPS um Daten sicher zu übertragen.
Alle eingebundenen Dateien werden ebenfalls über HTTPS ausgeliefert.

Medienliste

URLALT-AttributeTitel
...tent/uploads/2019/06/oncozine_270x90.pngOncoZine, The International Oncology NetworkOncoZine, The International Oncology Network
.../uploads/2019/06/oncozine-140x48_wht.pngOncoZine, The International Oncology NetworkOncoZine, The International Oncology Network
...tent/uploads/2019/06/oncozine_270x90.pngOncoZine, The International Oncology NetworkOncoZine, The International Oncology Network
...ads/2020/02/oncozine_brief-300x250-1.pngspot_img
...F4D-4F06-AB10-E80D755FFC56_4_5005_c.jpegspot_img
...ers-of-the-Cancer-Universe-300x250-1.jpgspot_img
.../uploads/2019/06/oncozine_270x90_wht.pngOnco\'Zine, The International Oncology NetworkOnco\'Zine, The International Oncology Network
...nt/uploads/2021/05/subcription-popup.pngKein ALT-Attribut angegeben

Seitenstruktur

H1 Überschrift
(Extrem wichtig)
Onco'Zine OncoZine, The International Oncology Network
Die H1-Überschrift ist perfekt.
Überschriften
(Wichtig)
Einige Überschriftentexte kommen doppelt auf der Seite vor.
Die Überschriftenstruktur ist fehlerhaft. Es sollte keine Hierarchie (H1-H6) ausgelassen werden.
Es befinden sich 61 Überschriften auf der Seite. Die Anzahl der Überschriften sollte in einem besseren Verhältnis zum Text stehen.

Überschriftenstruktur

Überschriften HierarchieInhalt
H1 Onco'Zine OncoZine, The International Oncology Network
H3 Solutions to Identify Patients for Recruitment in Early Oncology Clinical Trials
H3 Crofelemer Reduces Diarrhea in Humans and Dogs Being Treated for Cancer, Recent Studies Show
H3 Study Shows New Co-Star Receptor to be Promising in Cancer Treatment
H3 The Concierge Catch: Better Access for a Few Patients Disrupts Care for Many
H3 ASCO 2024: Encouraging Dose Escalation Data from Ongoing Phase 1 KisMET-01 Study of MYTX-011
H3 Solutions to Identify Patients for Recruitment in Early Oncology Clinical Trials Text-Duplikat
H3 Crofelemer Reduces Diarrhea in Humans and Dogs Being Treated for Cancer, Recent Studies Show Text-Duplikat
H3 The Concierge Catch: Better Access for a Few Patients Disrupts Care for Many Text-Duplikat
H3 The Transformative Potential of Exosome Research in Cancer Detection and Beyond
H3 A Global View of Oncology Informatics
H3 Standardizing Immunophenotyping Research Tools to Improve MDS and the Immune System
H3 Experts Forecast: Achieving Cancer Health Equity
H3 The Impact of DCISionRT Versus Clinicopathologic Factors Alone in Predicting Benefit of Radiation
H3 Solutions to Identify Patients for Recruitment in Early Oncology Clinical Trials Text-Duplikat
H3 Crofelemer Reduces Diarrhea in Humans and Dogs Being Treated for Cancer, Recent Studies Show Text-Duplikat
H3 Study Shows New Co-Star Receptor to be Promising in Cancer Treatment Text-Duplikat
H3 The Concierge Catch: Better Access for a Few Patients Disrupts Care for Many Text-Duplikat
H3 ASCO 2024: Encouraging Dose Escalation Data from Ongoing Phase 1 KisMET-01 Study of MYTX-011 Text-Duplikat
H3 ASCO 2024: Adagrasib Shows Statistically Significant Improvement in PFS in KRASG12C-Mutated NSCLC
H3 ASCO 2024: A More Effective Treatment Combination for Hodgkin Lymphoma
H3 ASCO 2024: Asciminib – A Safer + More Effective Option for Newly Diagnosed Chronic...
H3 ASCO 2024: Durable Efficacy of Lorlatinib as a first-line choice in ALK-positive NSCLC n
H3 ASCO 2024: NATALEE shows Ribociclib Reduces Risk of Cancer Recurrence in Early Breast Cancer
H3 ASCO 2024: AbbVie to Showcases Robust Solid Tumor Pipeline with New Data from Its...
H3 Strong Immunology Portfolio helps Offset losses of AbbVie’s Adalimumab
H3 ASCO 2024: Encouraging Dose Escalation Data from Ongoing Phase 1 KisMET-01 Study of MYTX-011 Text-Duplikat
H3 ASCO 2024: Adagrasib Shows Statistically Significant Improvement in PFS in KRASG12C-Mutated NSCLC Text-Duplikat
H3 ASCO 2024: A More Effective Treatment Combination for Hodgkin Lymphoma Text-Duplikat
H3 ASCO 2024: Asciminib – A Safer + More Effective Option for Newly Diagnosed Chronic... Text-Duplikat
H3 ASCO 2024: Durable Efficacy of Lorlatinib as a first-line choice in ALK-positive NSCLC n Text-Duplikat
H3 ASCO 2024: NATALEE shows Ribociclib Reduces Risk of Cancer Recurrence in Early Breast Cancer Text-Duplikat
H3 ASCO 2024: AbbVie to Showcases Robust Solid Tumor Pipeline with New Data from Its... Text-Duplikat
H3 ASCO 2024: Bristol Myers Squibb to Present Results from 130 Studies
H3 Encouraging Conversation & Action on Sexual Health and Fertility for Patients Diagnosed with Cancer
H3 Increased Overall Survival Reported for Combination of Durvalumab plus Chemotherapy
H3 Study Shows Positive Results in Treatment of Cervical High-Grade Squamous Intraepithelial Lesion
H3 Immunotherapy After Surgery Improves Survival in Patients with Kidney Cancer
H3 A Global View of Oncology Informatics Text-Duplikat
H3 Standardizing Immunophenotyping Research Tools to Improve MDS and the Immune System Text-Duplikat
H3 Experts Forecast: Achieving Cancer Health Equity Text-Duplikat
H3 The Impact of DCISionRT Versus Clinicopathologic Factors Alone in Predicting Benefit of Radiation Text-Duplikat
H3 Forecast 2024: Broadening the Reach of Cancer Vaccines
H3 The Digital Frontier: 5 Ways Oncology Informatics is Enhancing Cancer Care
H3 Remembering Emil “Jay” Freireich—the Man Who Made Vince DeVita a ‘Believer’
H3 Why Were Top HHS Officials? Interviews Thwarted by Their Press Offices?
H3 Jason Moore, PhD: Improving the Lives of Patients through Computing Technologies and Data Resources
H3 SonALAsense: Developing a Safe and Effective Noninvasive Treatment for Cancer
H3 Be The Match®: Improving Outcomes and Providing Hope to Patients in Need
H3 Solutions to Identify Patients for Recruitment in Early Oncology Clinical Trials Text-Duplikat
H3 Crofelemer Reduces Diarrhea in Humans and Dogs Being Treated for Cancer, Recent Studies Show Text-Duplikat
H3 Study Shows New Co-Star Receptor to be Promising in Cancer Treatment Text-Duplikat
H3 Daiichi Sankyo Out-Licenses Investigational Agent DS-6051 to AnHeart Therapeutics
H3 How Meaningful Will Changes Be to Ethical Guidelines Following Jose Baselga’s Fall?
H3 Reversal of Fortune: How a Vilified Drug Became a Life-saving Agent in the ‘War’...
H4 FEATURED
H4 NEWS
H4 CONFERENCE COVERAGE
H4 EDITORIAL
H4 ERIC ROSENTHAL REPORTS
H4 EXPERT INTERVIEWS
Einige der Linktexte wiederholen sich.
Die Anzahl an internen Links ist ok.
Keiner der Linktexte ist zu lang.
Alle internen Links haben keine dynamischen Parameter.
Es befinden sich zu viele externe Links (75) auf der Seite.

Gefundene Links auf dieser Seite

LinkAttributeLinktext
https://www.facebook.com/oncoz...Neues Fenster Extern Subdomain A-TITLE Facebook
https://www.linkedin.com/showc...Neues Fenster Extern Subdomain A-TITLE Linkedin
https://soundcloud.com/hofreyNeues Fenster Extern A-TITLE Soundcloud
https://twitter.com/OncoZineNeues Fenster Extern A-TITLE Twitter
https://vimeo.com/channels/877242Neues Fenster Extern A-TITLE Vimeo
https://www.youtube.com/channe...Neues Fenster Extern Subdomain A-TITLE Youtube
https://www.xing.com/communiti...Neues Fenster Extern Subdomain A-TITLE Xing
https://www.oncozine.com/Subdomain Home
/advertisement-sponsorship-opt...Subdomain Advertisement & Sponsorship Options
https://lp.constantcontactpage...Extern Subdomain Download Our Media Kit
/continued-medical-education-cme/Subdomain Changing Physician Behavior
/cancer-information-by-disease/Subdomain Cancer A – Z
http://www.oncozine.com/Subdomain Drug Developmemt Technologies
/a-novel-technology-based-on-s...Subdomain A Novel Technology based on Somatic Hypermutation (SHM)
/about-oncozine/advisory-board-3/Subdomain Editorial Advisory Board
/join-our-editorial-advisory-b...Subdomain Join Our Editorial Advisory Board
/contact-us/Subdomain Contact Us
/terms-and-conditions/Subdomain Terms and Conditions
/sabcs-and-ash-2023/Subdomain SABCS and ASH 2023
http://www.adcreview.com/Extern Subdomain ADC Review | J. Antibody-drug Conjugates
https://www.adcreview.com/reso...Extern Subdomain Resources for For Clinicians
https://www.adcreview.com/adc-...Extern Subdomain Drug Map (ADC)
https://www.adcreview.com/cate...Extern Subdomain Peer Review Articles
https://www.adcreview.com/the-...Extern Subdomain The Review
/changing-strategies-in-the-wa...Subdomain Changing Strategies in the War on Cancer
/changing-strategies-in-the-wa...Subdomain Changing Strategies in the War on Cancer – Episode 1
/changing-strategies-in-the-wa...Subdomain Changing Strategies in the War on Cancer – Episode 2
/changing-strategies-in-the-wa...Subdomain Changing Strategies in the War on Cancer – Episode 3
/centers-of-the-cancer-univers...Subdomain Centers of the Cancer Universe: A Half-Century of Progress Against Cancer
http://cartcelljournal.com/Extern Journal of CAR T-Cell Therapy
http://cartcelljournal.com/about/Extern About CAR T-cells
http://cartcelljournal.com/faq/Extern Frequently Asked Questions
http://cartcelljournal.com/art...Extern Types of Articles
http://cartcelljournal.com/for...Extern Submit a Manuscript
/the_oncozine_brief_episodes/Subdomain The Onco’Zine Brief
/the_oncozine_brief_episodes/Subdomain The Network
/the-oncozine-brief-episodes/Subdomain The Episodes
https://www.patreon.com/theonc...Neues Fenster Extern Subdomain How to Support The Onco’Zine Brief
/underwriting/Subdomain Corporate Underwriting and Sponsorship
/the-oncozine-dossier/Subdomain The Onco’Zine Dossier
/thalidomide-a-history/Subdomain Thalidomide: A History
/thalidomide-in-the-shadow-of-...Subdomain Thalidomide: In the Shadow of Death
/controversy-the-involvement-o...Subdomain Controversy: The involvement of Ciba AG in the development of Thalidomide
/thalidomides-secret-past-the-...Subdomain Thalidomide’s Secret Past: The Link with Nazi Germany
/reversal-of-fortune-how-a-vil...Subdomain Reversal of Fortune: How a Vilified Drug Became a Life-saving Agent in the ‘War’ Against Cancer
/oncozine-dossier-50-years-aft...Subdomain Smoking and Health
/new-surgeon-generals-report-p...Subdomain New Surgeon General’s Report Presents the Unfiltered Truth About Tobacco
/smoking-and-the-lost-legacy-o...Subdomain Smoking and the Lost Legacy of the First Surgeon General’s Report on Smoking and Health
/tobacco-control-in-the-united...Subdomain Tobacco Control in the United States Has Saved 8 Million Lives In Last 50 Years
http://.com/tobacco-companies-...Extern Tobacco Companies are Finally Moving Closer to Revealing the Truth about Smoking
/the-harmful-effects-of-smokin...Subdomain The Harmful Effects of Smoking: The Public Denial in the Early-mid 1960s
/oncozine.com/oncology-hematol...Subdomain Drug Approvals 2017 – 2020
/oncology-hematology-drug-appr...Subdomain Oncology & Hematology – FDA Drug Approvals 2018
/oncology-hematology-fda-drug-...Subdomain Oncology & Hematology – FDA Drug Approvals 2019
/oncology-hematology-fda-drug-...Subdomain Oncology & Hematology – FDA Drug Approvals 2020
/category/articles/Subdomain Articles
/category/latest-articles/Subdomain Latest Articles
/category/expert-interviews/Subdomain Expert Interviews
/category/editorial-and-commen...Subdomain Editorials and Commentaries
/category/eric-rosenthal-reports/Subdomain Eric Rosenthal Reports
/category/publications-peer-re...Subdomain Publications
/category/news/Subdomain News
/category/business-economics/Subdomain Business & Economics
/category/clinical-development/Subdomain Clinical Development
/category/conference-coverage/Subdomain Conference Coverage
/the_oncozine_brief_episodes/Subdomain Textduplikat The Onco’Zine Brief
/the-oncozine-brief-episodes/Subdomain Textduplikat The Episodes
/the-oncozine-brief-national-a...Subdomain National Advertising
http://www.oncozine.com/Neues Fenster Subdomain Resources
https://www.oncologydirectory....Neues Fenster Extern Subdomain Membership
https://www.oncologydirectory....Extern Subdomain Agenda
https://www.oncologydirectory....Neues Fenster Extern Subdomain Join Today
https://www.oncologydirectory....Neues Fenster Extern Subdomain Video
/job-openings/Subdomain Careers
/about-oncozine/about-oncozine-2/Subdomain About
/about-oncozine/advertise-with...Subdomain Advertise
/about-oncozine/advisory-board...Subdomain Advisory Board
/contact-us/Subdomain Textduplikat Contact Us
https://www.facebook.com/oncoz...Neues Fenster Extern Subdomain Textduplikat A-TITLE Facebook
https://www.linkedin.com/showc...Neues Fenster Extern Subdomain Textduplikat A-TITLE Linkedin
https://soundcloud.com/hofreyNeues Fenster Extern Textduplikat A-TITLE Soundcloud
https://twitter.com/OncoZineNeues Fenster Extern Textduplikat A-TITLE Twitter
https://vimeo.com/channels/877242Neues Fenster Extern Textduplikat A-TITLE Vimeo
https://www.youtube.com/channe...Neues Fenster Extern Subdomain Textduplikat A-TITLE Youtube
https://www.xing.com/communiti...Neues Fenster Extern Subdomain Textduplikat A-TITLE Xing
https://www.oncozine.com/Subdomain Onco'Zine
IMG-ALT OncoZine, The International Oncology Network
https://www.oncozine.com/Subdomain IMG-ALT OncoZine, The International Oncology Network
https://www.oncozine.com/Subdomain Textduplikat IMG-ALT OncoZine, The International Oncology Network
https://www.oncozine.com/Subdomain Textduplikat Home
/advertisement-sponsorship-opt...Subdomain Textduplikat Advertisement & Sponsorship Options
https://lp.constantcontactpage...Extern Subdomain Textduplikat Download Our Media Kit
/continued-medical-education-cme/Subdomain Textduplikat Changing Physician Behavior
/cancer-information-by-disease/Subdomain Textduplikat Cancer A – Z
http://www.oncozine.com/Subdomain Textduplikat Drug Developmemt Technologies
/a-novel-technology-based-on-s...Subdomain Textduplikat A Novel Technology based on Somatic Hypermutation (SHM)
/about-oncozine/advisory-board-3/Subdomain Textduplikat Editorial Advisory Board
/join-our-editorial-advisory-b...Subdomain Textduplikat Join Our Editorial Advisory Board
/contact-us/Subdomain Textduplikat Contact Us
/terms-and-conditions/Subdomain Textduplikat Terms and Conditions
/sabcs-and-ash-2023/Subdomain Textduplikat SABCS and ASH 2023
http://www.adcreview.com/Extern Subdomain Textduplikat ADC Review | J. Antibody-drug Conjugates
https://www.adcreview.com/reso...Extern Subdomain Textduplikat Resources for For Clinicians
https://www.adcreview.com/adc-...Extern Subdomain Textduplikat Drug Map (ADC)
https://www.adcreview.com/cate...Extern Subdomain Textduplikat Peer Review Articles
https://www.adcreview.com/the-...Extern Subdomain Textduplikat The Review
/changing-strategies-in-the-wa...Subdomain Textduplikat Changing Strategies in the War on Cancer
/changing-strategies-in-the-wa...Subdomain Textduplikat Changing Strategies in the War on Cancer – Episode 1
/changing-strategies-in-the-wa...Subdomain Textduplikat Changing Strategies in the War on Cancer – Episode 2
/changing-strategies-in-the-wa...Subdomain Textduplikat Changing Strategies in the War on Cancer – Episode 3
/centers-of-the-cancer-univers...Subdomain Textduplikat Centers of the Cancer Universe: A Half-Century of Progress Against Cancer
http://cartcelljournal.com/Extern Textduplikat Journal of CAR T-Cell Therapy
http://cartcelljournal.com/about/Extern Textduplikat About CAR T-cells
http://cartcelljournal.com/faq/Extern Textduplikat Frequently Asked Questions
http://cartcelljournal.com/art...Extern Textduplikat Types of Articles
http://cartcelljournal.com/for...Extern Textduplikat Submit a Manuscript
/the_oncozine_brief_episodes/Subdomain Textduplikat The Onco’Zine Brief
/the_oncozine_brief_episodes/Subdomain Textduplikat The Network
/the-oncozine-brief-episodes/Subdomain Textduplikat The Episodes
https://www.patreon.com/theonc...Neues Fenster Extern Subdomain Textduplikat How to Support The Onco’Zine Brief
/underwriting/Subdomain Textduplikat Corporate Underwriting and Sponsorship
/the-oncozine-dossier/Subdomain Textduplikat The Onco’Zine Dossier
/thalidomide-a-history/Subdomain Textduplikat Thalidomide: A History
/thalidomide-in-the-shadow-of-...Subdomain Textduplikat Thalidomide: In the Shadow of Death
/controversy-the-involvement-o...Subdomain Textduplikat Controversy: The involvement of Ciba AG in the development of Thalidomide
/thalidomides-secret-past-the-...Subdomain Textduplikat Thalidomide’s Secret Past: The Link with Nazi Germany
/reversal-of-fortune-how-a-vil...Subdomain Textduplikat Reversal of Fortune: How a Vilified Drug Became a Life-saving Agent in the ‘War’ Against Cancer
/oncozine-dossier-50-years-aft...Subdomain Textduplikat Smoking and Health
/new-surgeon-generals-report-p...Subdomain Textduplikat New Surgeon General’s Report Presents the Unfiltered Truth About Tobacco
/smoking-and-the-lost-legacy-o...Subdomain Textduplikat Smoking and the Lost Legacy of the First Surgeon General’s Report on Smoking and Health
/tobacco-control-in-the-united...Subdomain Textduplikat Tobacco Control in the United States Has Saved 8 Million Lives In Last 50 Years
http://.com/tobacco-companies-...Extern Textduplikat Tobacco Companies are Finally Moving Closer to Revealing the Truth about Smoking
/the-harmful-effects-of-smokin...Subdomain Textduplikat The Harmful Effects of Smoking: The Public Denial in the Early-mid 1960s
/oncozine.com/oncology-hematol...Subdomain Textduplikat Drug Approvals 2017 – 2020
/oncology-hematology-drug-appr...Subdomain Textduplikat Oncology & Hematology – FDA Drug Approvals 2018
/oncology-hematology-fda-drug-...Subdomain Textduplikat Oncology & Hematology – FDA Drug Approvals 2019
/oncology-hematology-fda-drug-...Subdomain Textduplikat Oncology & Hematology – FDA Drug Approvals 2020
/category/articles/Subdomain Textduplikat Articles
/category/latest-articles/Subdomain Textduplikat Latest Articles
/category/expert-interviews/Subdomain Textduplikat Expert Interviews
/category/editorial-and-commen...Subdomain Textduplikat Editorials and Commentaries
/category/eric-rosenthal-reports/Subdomain Textduplikat Eric Rosenthal Reports
/category/publications-peer-re...Subdomain Textduplikat Publications
/category/news/Subdomain Textduplikat News
/category/business-economics/Subdomain Textduplikat Business & Economics
/category/clinical-development/Subdomain Textduplikat Clinical Development
/category/conference-coverage/Subdomain Textduplikat Conference Coverage
/the_oncozine_brief_episodes/Subdomain Textduplikat The Onco’Zine Brief
/the-oncozine-brief-episodes/Subdomain Textduplikat The Episodes
/the-oncozine-brief-national-a...Subdomain Textduplikat National Advertising
http://www.oncozine.com/Neues Fenster Subdomain Textduplikat Resources
https://www.oncologydirectory....Neues Fenster Extern Subdomain Textduplikat Membership
https://www.oncologydirectory....Extern Subdomain Textduplikat Agenda
https://www.oncologydirectory....Neues Fenster Extern Subdomain Textduplikat Join Today
https://www.oncologydirectory....Neues Fenster Extern Subdomain Textduplikat Video
/job-openings/Subdomain Textduplikat Careers
/solutions-to-identify-patient...Subdomain A-TITLE Solutions to Identify Patients for Recruitment in Early Oncology Clinical Trials
/solutions-to-identify-patient...Subdomain Textduplikat Solutions to Identify Patients for Recruitment in Early Oncology Clinical Trials
A-TITLE Solutions to Identify Patients for Recruitment in Early Oncology Clinical Trials
/author/kimberly_futch_001_bs-...Subdomain Kimberly Futch
/crofelemer-reduces-diarrhea-i...Subdomain A-TITLE Crofelemer Reduces Diarrhea in Humans and Dogs Being Treated for Cancer, Recent Studies Show
/crofelemer-reduces-diarrhea-i...Subdomain Textduplikat Crofelemer Reduces Diarrhea in Humans and Dogs Being Treated for Cancer, Recent Studies Show
A-TITLE Crofelemer Reduces Diarrhea in Humans and Dogs Being Treated for Cancer, Recent Studies Show
/study-shows-new-co-star-recep...Subdomain A-TITLE Study Shows New Co-Star Receptor to be Promising in Cancer Treatment
/study-shows-new-co-star-recep...Subdomain Textduplikat Study Shows New Co-Star Receptor to be Promising in Cancer Treatment
A-TITLE Study Shows New Co-Star Receptor to be Promising in Cancer Treatment
/the-concierge-catch-better-ac...Subdomain A-TITLE The Concierge Catch: Better Access for a Few Patients Disrupts Care for Many
/the-concierge-catch-better-ac...Subdomain Textduplikat The Concierge Catch: Better Access for a Few Patients Disrupts Care for Many
A-TITLE The Concierge Catch: Better Access for a Few Patients Disrupts Care for Many
/asco-2024-encouraging-dose-es...Subdomain A-TITLE ASCO 2024: Encouraging Dose Escalation Data from Ongoing Phase 1 KisMET-01 Study of MYTX-011
/asco-2024-encouraging-dose-es...Subdomain Textduplikat ASCO 2024: Encouraging Dose Escalation Data from Ongoing Phase 1 KisMET-01 Study of MYTX-011
A-TITLE ASCO 2024: Encouraging Dose Escalation Data from Ongoing Phase 1 KisMET-01 Study of MYTX-011
/category/featured/Subdomain FEATURED
/solutions-to-identify-patient...Subdomain Textduplikat Solutions to Identify Patients for Recruitment in Early Oncology Clinical Trials
A-TITLE Solutions to Identify Patients for Recruitment in Early Oncology Clinical Trials
/author/kimberly_futch_001_bs-...Subdomain Textduplikat Kimberly Futch
/crofelemer-reduces-diarrhea-i...Subdomain Textduplikat Crofelemer Reduces Diarrhea in Humans and Dogs Being Treated for Cancer, Recent Studies Show
A-TITLE Crofelemer Reduces Diarrhea in Humans and Dogs Being Treated for Cancer, Recent Studies Show
/author/okhuysen_pc-001/Subdomain Pablo C. Okhuysen, M.D., FACP, FIDSA
/the-concierge-catch-better-ac...Subdomain Textduplikat The Concierge Catch: Better Access for a Few Patients Disrupts Care for Many
A-TITLE The Concierge Catch: Better Access for a Few Patients Disrupts Care for Many
/author/john-rossheim_001a/Subdomain John Rossheim
/the-transformative-potential-...Subdomain The Transformative Potential of Exosome Research in Cancer Detection and Beyond
A-TITLE The Transformative Potential of Exosome Research in Cancer Detection and Beyond
/author/biological_d-hdhani_001/Subdomain Harmeet Dhani, MD, MSc
/a-global-view-of-oncology-inf...Subdomain A Global View of Oncology Informatics
A-TITLE A Global View of Oncology Informatics
/author/maria_dolores-mata-moy...Subdomain María Dolores de la Mata Moya
/standardizing-immunophenotypi...Subdomain Standardizing Immunophenotyping Research Tools to Improve MDS and the Immune System
A-TITLE Standardizing Immunophenotyping Research Tools to Improve MDS and the Immune System
/author/leonardo_beretta_001-ad/Subdomain Leonardo Beretta
/experts-forecast-achieving-ca...Subdomain Experts Forecast: Achieving Cancer Health Equity
A-TITLE Experts Forecast: Achieving Cancer Health Equity
/author/neha_j_pancholi_001/Subdomain Neha J. Pancholi, PhD
/the-impact-of-dcisionrt-versu...Subdomain The Impact of DCISionRT Versus Clinicopathologic Factors Alone in Predicting Benefit of Radiation
A-TITLE The Impact of DCISionRT Versus Clinicopathologic Factors Alone in Predicting Benefit of Radiation
/author/amishi-bajaj-001/Subdomain Amishi Bajaj, MD
/category/newsSubdomain NEWS
/solutions-to-identify-patient...Subdomain Textduplikat Solutions to Identify Patients for Recruitment in Early Oncology Clinical Trials
A-TITLE Solutions to Identify Patients for Recruitment in Early Oncology Clinical Trials
/author/kimberly_futch_001_bs-...Subdomain Textduplikat Kimberly Futch
/crofelemer-reduces-diarrhea-i...Subdomain Textduplikat Crofelemer Reduces Diarrhea in Humans and Dogs Being Treated for Cancer, Recent Studies Show
A-TITLE Crofelemer Reduces Diarrhea in Humans and Dogs Being Treated for Cancer, Recent Studies Show
/author/okhuysen_pc-001/Subdomain Textduplikat Pablo C. Okhuysen, M.D., FACP, FIDSA
/study-shows-new-co-star-recep...Subdomain Textduplikat Study Shows New Co-Star Receptor to be Promising in Cancer Treatment
A-TITLE Study Shows New Co-Star Receptor to be Promising in Cancer Treatment
/author/peter-hofland/Subdomain Peter Hofland
/the-concierge-catch-better-ac...Subdomain Textduplikat The Concierge Catch: Better Access for a Few Patients Disrupts Care for Many
A-TITLE The Concierge Catch: Better Access for a Few Patients Disrupts Care for Many
/author/john-rossheim_001a/Subdomain Textduplikat John Rossheim
/asco-2024-encouraging-dose-es...Subdomain Textduplikat ASCO 2024: Encouraging Dose Escalation Data from Ongoing Phase 1 KisMET-01 Study of MYTX-011
A-TITLE ASCO 2024: Encouraging Dose Escalation Data from Ongoing Phase 1 KisMET-01 Study of MYTX-011
/author/editorial_team/Subdomain Editorial Team
/asco-2024-adagrasib-shows-sta...Subdomain ASCO 2024: Adagrasib Shows Statistically Significant Improvement in PFS in KRASG12C-Mutated NSCLC
A-TITLE ASCO 2024: Adagrasib Shows Statistically Significant Improvement in PFS in KRASG12C-Mutated NSCLC
/author/editorial_team/Subdomain Textduplikat Editorial Team
/asco-2024-a-more-effective-tr...Subdomain ASCO 2024: A More Effective Treatment Combination for Hodgkin Lymphoma
A-TITLE ASCO 2024: A More Effective Treatment Combination for Hodgkin Lymphoma
/author/editorial_team/Subdomain Textduplikat Editorial Team
/asco-2024-asciminib-a-safer-m...Subdomain ASCO 2024: Asciminib – A Safer + More Effective Option for Newly Diagnosed Chronic...
A-TITLE ASCO 2024: Asciminib – A Safer + More Effective Option for Newly Diagnosed Chronic Myeloid Leukemia
/author/editorial_team/Subdomain Textduplikat Editorial Team
/asco-2024-durable-efficacy-of...Subdomain ASCO 2024: Durable Efficacy of Lorlatinib as a first-line choice in ALK-positive NSCLC n
A-TITLE ASCO 2024: Durable Efficacy of Lorlatinib as a first-line choice in ALK-positive NSCLC n
/author/editorial_team/Subdomain Textduplikat Editorial Team
/asco-2024-natalee-shows-riboc...Subdomain ASCO 2024: NATALEE shows Ribociclib Reduces Risk of Cancer Recurrence in Early Breast Cancer
A-TITLE ASCO 2024: NATALEE shows Ribociclib Reduces Risk of Cancer Recurrence in Early Breast Cancer
/author/editorial_team/Subdomain Textduplikat Editorial Team
/asco-2024-abbvie-to-showcases...Subdomain ASCO 2024: AbbVie to Showcases Robust Solid Tumor Pipeline with New Data from Its...
A-TITLE ASCO 2024: AbbVie to Showcases Robust Solid Tumor Pipeline with New Data from Its ADC Platform
/author/editorial_team/Subdomain Textduplikat Editorial Team
/strong-immunology-portfolio-h...Subdomain Strong Immunology Portfolio helps Offset losses of AbbVie’s Adalimumab
A-TITLE Strong Immunology Portfolio helps Offset losses of AbbVie’s Adalimumab
/author/editorial_team/Subdomain Textduplikat Editorial Team
/asco-2024-encouraging-dose-es...Subdomain Textduplikat ASCO 2024: Encouraging Dose Escalation Data from Ongoing Phase 1 KisMET-01 Study of MYTX-011
A-TITLE ASCO 2024: Encouraging Dose Escalation Data from Ongoing Phase 1 KisMET-01 Study of MYTX-011
/author/editorial_team/Subdomain Textduplikat Editorial Team
/asco-2024-adagrasib-shows-sta...Subdomain Textduplikat ASCO 2024: Adagrasib Shows Statistically Significant Improvement in PFS in KRASG12C-Mutated NSCLC
A-TITLE ASCO 2024: Adagrasib Shows Statistically Significant Improvement in PFS in KRASG12C-Mutated NSCLC
/author/editorial_team/Subdomain Textduplikat Editorial Team
/asco-2024-a-more-effective-tr...Subdomain Textduplikat ASCO 2024: A More Effective Treatment Combination for Hodgkin Lymphoma
A-TITLE ASCO 2024: A More Effective Treatment Combination for Hodgkin Lymphoma
/author/editorial_team/Subdomain Textduplikat Editorial Team
/asco-2024-asciminib-a-safer-m...Subdomain Textduplikat ASCO 2024: Asciminib – A Safer + More Effective Option for Newly Diagnosed Chronic...
A-TITLE ASCO 2024: Asciminib – A Safer + More Effective Option for Newly Diagnosed Chronic Myeloid Leukemia
/author/editorial_team/Subdomain Textduplikat Editorial Team
/asco-2024-durable-efficacy-of...Subdomain Textduplikat ASCO 2024: Durable Efficacy of Lorlatinib as a first-line choice in ALK-positive NSCLC n
A-TITLE ASCO 2024: Durable Efficacy of Lorlatinib as a first-line choice in ALK-positive NSCLC n
/author/editorial_team/Subdomain Textduplikat Editorial Team
/asco-2024-natalee-shows-riboc...Subdomain Textduplikat ASCO 2024: NATALEE shows Ribociclib Reduces Risk of Cancer Recurrence in Early Breast Cancer
A-TITLE ASCO 2024: NATALEE shows Ribociclib Reduces Risk of Cancer Recurrence in Early Breast Cancer
/author/editorial_team/Subdomain Textduplikat Editorial Team
/asco-2024-abbvie-to-showcases...Subdomain Textduplikat ASCO 2024: AbbVie to Showcases Robust Solid Tumor Pipeline with New Data from Its...
A-TITLE ASCO 2024: AbbVie to Showcases Robust Solid Tumor Pipeline with New Data from Its ADC Platform
/author/editorial_team/Subdomain Textduplikat Editorial Team
/asco-2024-bristol-myers-squib...Subdomain ASCO 2024: Bristol Myers Squibb to Present Results from 130 Studies
A-TITLE ASCO 2024: Bristol Myers Squibb to Present Results from 130 Studies
/author/editorial_team/Subdomain Textduplikat Editorial Team
/encouraging-conversation-acti...Subdomain Encouraging Conversation & Action on Sexual Health and Fertility for Patients Diagnosed with Cancer
A-TITLE Encouraging Conversation & Action on Sexual Health and Fertility for Patients Diagnosed with Cancer
/author/editorial_team/Subdomain Textduplikat Editorial Team
/increased-overall-survival-re...Subdomain Increased Overall Survival Reported for Combination of Durvalumab plus Chemotherapy
A-TITLE Increased Overall Survival Reported for Combination of Durvalumab plus Chemotherapy
/author/peter-hofland/Subdomain Textduplikat Peter Hofland
/study-shows-positive-results-...Subdomain Study Shows Positive Results in Treatment of Cervical High-Grade Squamous Intraepithelial Lesion
A-TITLE Study Shows Positive Results in Treatment of Cervical High-Grade Squamous Intraepithelial Lesion
/author/editorial_team/Subdomain Textduplikat Editorial Team
/immunotherapy-after-surgery-i...Subdomain Immunotherapy After Surgery Improves Survival in Patients with Kidney Cancer
A-TITLE Immunotherapy After Surgery Improves Survival in Patients with Kidney Cancer
/author/editorial_team/Subdomain Textduplikat Editorial Team
/category/editorial/Subdomain EDITORIAL
/a-global-view-of-oncology-inf...Subdomain Textduplikat A Global View of Oncology Informatics
A-TITLE A Global View of Oncology Informatics
/author/maria_dolores-mata-moy...Subdomain Textduplikat María Dolores de la Mata Moya
/standardizing-immunophenotypi...Subdomain Textduplikat Standardizing Immunophenotyping Research Tools to Improve MDS and the Immune System
A-TITLE Standardizing Immunophenotyping Research Tools to Improve MDS and the Immune System
/author/leonardo_beretta_001-ad/Subdomain Textduplikat Leonardo Beretta
/experts-forecast-achieving-ca...Subdomain Textduplikat Experts Forecast: Achieving Cancer Health Equity
A-TITLE Experts Forecast: Achieving Cancer Health Equity
/author/neha_j_pancholi_001/Subdomain Textduplikat Neha J. Pancholi, PhD
/the-impact-of-dcisionrt-versu...Subdomain Textduplikat The Impact of DCISionRT Versus Clinicopathologic Factors Alone in Predicting Benefit of Radiation
A-TITLE The Impact of DCISionRT Versus Clinicopathologic Factors Alone in Predicting Benefit of Radiation
/author/amishi-bajaj-001/Subdomain Textduplikat Amishi Bajaj, MD
/forecast-2024-broadening-the-...Subdomain Forecast 2024: Broadening the Reach of Cancer Vaccines
A-TITLE Forecast 2024: Broadening the Reach of Cancer Vaccines
/author/neha_j_pancholi_001/Subdomain Textduplikat Neha J. Pancholi, PhD
/the-digital-frontier-5-ways-o...Subdomain The Digital Frontier: 5 Ways Oncology Informatics is Enhancing Cancer Care
A-TITLE The Digital Frontier: 5 Ways Oncology Informatics is Enhancing Cancer Care
/author/jesse-kaestner-001/Subdomain Jesse Kaestner
/category/eric-rosenthal-reports/Subdomain ERIC ROSENTHAL REPORTS
/remembering-emil-jay-freireic...Subdomain Remembering Emil “Jay” Freireich—the Man Who Made Vince DeVita a ‘Believer’
A-TITLE Remembering Emil “Jay” Freireich—the Man Who Made Vince DeVita a ‘Believer’
/author/erictrosenthal/Subdomain Eric T. Rosenthal
/why-were-top-hhs-officials-in...Subdomain Why Were Top HHS Officials? Interviews Thwarted by Their Press Offices?
A-TITLE Why Were Top HHS Officials? Interviews Thwarted by Their Press Offices?
/author/erictrosenthal/Subdomain Textduplikat Eric T. Rosenthal
/category/expert-interviews/Subdomain EXPERT INTERVIEWS
/jason-moore-phd-improving-the...Subdomain Jason Moore, PhD: Improving the Lives of Patients through Computing Technologies and Data Resources
A-TITLE Jason Moore, PhD: Improving the Lives of Patients through Computing Technologies and Data Resources
/author/editorial_team/Subdomain Textduplikat Editorial Team
/sonalasense-developing-a-safe...Subdomain SonALAsense: Developing a Safe and Effective Noninvasive Treatment for Cancer
A-TITLE SonALAsense: Developing a Safe and Effective Noninvasive Treatment for Cancer
/author/danielle_garcia/Subdomain Danielle Garcia
/be-the-match-improving-outcom...Subdomain Be The Match®: Improving Outcomes and Providing Hope to Patients in Need
A-TITLE Be The Match®: Improving Outcomes and Providing Hope to Patients in Need
/author/danielle_garcia/Subdomain Textduplikat Danielle Garcia
/the-oncozine-brief-episodes/Subdomain IMG-ALT spot_img
https://amzn.to/378W1I6Extern Textduplikat IMG-ALT spot_img
https://amzn.to/3Z0DFEUExtern Textduplikat IMG-ALT spot_img
/solutions-to-identify-patient...Subdomain Textduplikat Solutions to Identify Patients for Recruitment in Early Oncology Clinical Trials
A-TITLE Solutions to Identify Patients for Recruitment in Early Oncology Clinical Trials
/author/kimberly_futch_001_bs-...Subdomain Textduplikat Kimberly Futch
/crofelemer-reduces-diarrhea-i...Subdomain Textduplikat Crofelemer Reduces Diarrhea in Humans and Dogs Being Treated for Cancer, Recent Studies Show
A-TITLE Crofelemer Reduces Diarrhea in Humans and Dogs Being Treated for Cancer, Recent Studies Show
/author/okhuysen_pc-001/Subdomain Textduplikat Pablo C. Okhuysen, M.D., FACP, FIDSA
/study-shows-new-co-star-recep...Subdomain Textduplikat Study Shows New Co-Star Receptor to be Promising in Cancer Treatment
A-TITLE Study Shows New Co-Star Receptor to be Promising in Cancer Treatment
/author/peter-hofland/Subdomain Textduplikat Peter Hofland
/daiichi-sankyo-out-licenses-i...Subdomain Daiichi Sankyo Out-Licenses Investigational Agent DS-6051 to AnHeart Therapeutics
A-TITLE Daiichi Sankyo Out-Licenses Investigational Agent DS-6051 to AnHeart Therapeutics
/author/peter-hofland/Subdomain Textduplikat Peter Hofland
/how-meaningful-will-changes-b...Subdomain How Meaningful Will Changes Be to Ethical Guidelines Following Jose Baselga’s Fall?
A-TITLE How Meaningful Will Changes Be to Ethical Guidelines Following Jose Baselga’s Fall?
/author/erictrosenthal/Subdomain Textduplikat Eric T. Rosenthal
/reversal-of-fortune-how-a-vil...Subdomain Reversal of Fortune: How a Vilified Drug Became a Life-saving Agent in the ‘War’...
A-TITLE Reversal of Fortune: How a Vilified Drug Became a Life-saving Agent in the ‘War’ Against Cancer
/author/peter-hofland/Subdomain Textduplikat Peter Hofland
/category/news/Subdomain News2935
/category/conference-coverage/Subdomain Conference Coverage507
/category/research-and-develop...Subdomain Research & Development364
/category/cancer-risk/Subdomain Cancer Risk304
/category/clinical-trial-updates/Subdomain Clinical Trial Updates277
/category/clinical-development/Subdomain Clinical development271
/category/business-economics/Subdomain Business & Economics197
/category/regulatory-updates/Subdomain Regulatory Updates120
/category/op-ed-opinion/Subdomain Op-Ed | Opinion112
/category/must-read-articles/Subdomain Must Read Articles110
https://www.oncozine.com/Subdomain IMG-ALT Onco\'Zine, The International Oncology Network
https://www.facebook.com/oncoz...Neues Fenster Extern Subdomain Textduplikat A-TITLE Facebook
https://www.linkedin.com/showc...Neues Fenster Extern Subdomain Textduplikat A-TITLE Linkedin
https://soundcloud.com/hofreyNeues Fenster Extern Textduplikat A-TITLE Soundcloud
https://twitter.com/OncoZineNeues Fenster Extern Textduplikat A-TITLE Twitter
https://vimeo.com/channels/877242Neues Fenster Extern Textduplikat A-TITLE Vimeo
https://www.youtube.com/channe...Neues Fenster Extern Subdomain Textduplikat A-TITLE Youtube
https://www.xing.com/communiti...Neues Fenster Extern Subdomain Textduplikat A-TITLE Xing
https://www.oncozine.com/Subdomain Textduplikat Home
/advertisement-sponsorship-opt...Subdomain Textduplikat Advertisement & Sponsorship Options
https://lp.constantcontactpage...Extern Subdomain Textduplikat Download Our Media Kit
/continued-medical-education-cme/Subdomain Textduplikat Changing Physician Behavior
/cancer-information-by-disease/Subdomain Textduplikat Cancer A – Z
http://www.oncozine.com/Subdomain Textduplikat Drug Developmemt Technologies
/a-novel-technology-based-on-s...Subdomain Textduplikat A Novel Technology based on Somatic Hypermutation (SHM)
/about-oncozine/advisory-board-3/Subdomain Textduplikat Editorial Advisory Board
/join-our-editorial-advisory-b...Subdomain Textduplikat Join Our Editorial Advisory Board
/contact-us/Subdomain Textduplikat Contact Us
/terms-and-conditions/Subdomain Textduplikat Terms and Conditions
/sabcs-and-ash-2023/Subdomain Textduplikat SABCS and ASH 2023
http://www.adcreview.com/Extern Subdomain Textduplikat ADC Review | J. Antibody-drug Conjugates
https://www.adcreview.com/reso...Extern Subdomain Textduplikat Resources for For Clinicians
https://www.adcreview.com/adc-...Extern Subdomain Textduplikat Drug Map (ADC)
https://www.adcreview.com/cate...Extern Subdomain Textduplikat Peer Review Articles
https://www.adcreview.com/the-...Extern Subdomain Textduplikat The Review
/changing-strategies-in-the-wa...Subdomain Textduplikat Changing Strategies in the War on Cancer
/changing-strategies-in-the-wa...Subdomain Textduplikat Changing Strategies in the War on Cancer – Episode 1
/changing-strategies-in-the-wa...Subdomain Textduplikat Changing Strategies in the War on Cancer – Episode 2
/changing-strategies-in-the-wa...Subdomain Textduplikat Changing Strategies in the War on Cancer – Episode 3
/centers-of-the-cancer-univers...Subdomain Textduplikat Centers of the Cancer Universe: A Half-Century of Progress Against Cancer
http://cartcelljournal.com/Extern Textduplikat Journal of CAR T-Cell Therapy
http://cartcelljournal.com/about/Extern Textduplikat About CAR T-cells
http://cartcelljournal.com/faq/Extern Textduplikat Frequently Asked Questions
http://cartcelljournal.com/art...Extern Textduplikat Types of Articles
http://cartcelljournal.com/for...Extern Textduplikat Submit a Manuscript
/the_oncozine_brief_episodes/Subdomain Textduplikat The Onco’Zine Brief
/the_oncozine_brief_episodes/Subdomain Textduplikat The Network
/the-oncozine-brief-episodes/Subdomain Textduplikat The Episodes
https://www.patreon.com/theonc...Neues Fenster Extern Subdomain Textduplikat How to Support The Onco’Zine Brief
/underwriting/Subdomain Textduplikat Corporate Underwriting and Sponsorship
/the-oncozine-dossier/Subdomain Textduplikat The Onco’Zine Dossier
/thalidomide-a-history/Subdomain Textduplikat Thalidomide: A History
/thalidomide-in-the-shadow-of-...Subdomain Textduplikat Thalidomide: In the Shadow of Death
/controversy-the-involvement-o...Subdomain Textduplikat Controversy: The involvement of Ciba AG in the development of Thalidomide
/thalidomides-secret-past-the-...Subdomain Textduplikat Thalidomide’s Secret Past: The Link with Nazi Germany
/reversal-of-fortune-how-a-vil...Subdomain Textduplikat Reversal of Fortune: How a Vilified Drug Became a Life-saving Agent in the ‘War’ Against Cancer
/oncozine-dossier-50-years-aft...Subdomain Textduplikat Smoking and Health
/new-surgeon-generals-report-p...Subdomain Textduplikat New Surgeon General’s Report Presents the Unfiltered Truth About Tobacco
/smoking-and-the-lost-legacy-o...Subdomain Textduplikat Smoking and the Lost Legacy of the First Surgeon General’s Report on Smoking and Health
/tobacco-control-in-the-united...Subdomain Textduplikat Tobacco Control in the United States Has Saved 8 Million Lives In Last 50 Years
http://.com/tobacco-companies-...Extern Textduplikat Tobacco Companies are Finally Moving Closer to Revealing the Truth about Smoking
/the-harmful-effects-of-smokin...Subdomain Textduplikat The Harmful Effects of Smoking: The Public Denial in the Early-mid 1960s
/oncozine.com/oncology-hematol...Subdomain Textduplikat Drug Approvals 2017 – 2020
/oncology-hematology-drug-appr...Subdomain Textduplikat Oncology & Hematology – FDA Drug Approvals 2018
/oncology-hematology-fda-drug-...Subdomain Textduplikat Oncology & Hematology – FDA Drug Approvals 2019
/oncology-hematology-fda-drug-...Subdomain Textduplikat Oncology & Hematology – FDA Drug Approvals 2020
/category/articles/Subdomain Textduplikat Articles
/category/latest-articles/Subdomain Textduplikat Latest Articles
/category/expert-interviews/Subdomain Textduplikat Expert Interviews
/category/editorial-and-commen...Subdomain Textduplikat Editorials and Commentaries
/category/eric-rosenthal-reports/Subdomain Textduplikat Eric Rosenthal Reports
/category/publications-peer-re...Subdomain Textduplikat Publications
/category/news/Subdomain Textduplikat News
/category/business-economics/Subdomain Textduplikat Business & Economics
/category/clinical-development/Subdomain Textduplikat Clinical Development
/category/conference-coverage/Subdomain Textduplikat Conference Coverage
/the_oncozine_brief_episodes/Subdomain Textduplikat The Onco’Zine Brief
/the-oncozine-brief-episodes/Subdomain Textduplikat The Episodes
/the-oncozine-brief-national-a...Subdomain Textduplikat National Advertising
http://www.oncozine.com/Neues Fenster Subdomain Textduplikat Resources
https://www.oncologydirectory....Neues Fenster Extern Subdomain Textduplikat Membership
https://www.oncologydirectory....Extern Subdomain Textduplikat Agenda
https://www.oncologydirectory....Neues Fenster Extern Subdomain Textduplikat Join Today
https://www.oncologydirectory....Neues Fenster Extern Subdomain Textduplikat Video
/job-openings/Subdomain Textduplikat Careers
https://lp.constantcontactpage...Neues Fenster Extern Subdomain Kein Text

Serverkonfiguration

HTTP-Weiterleitungen
(Extrem wichtig)
Die Seite leitet weiter auf "https://www.oncozine.com/"
HTTP-Header
(Wichtig)
Es wird kein X-Powered HTTP-Header mitgesendet.
Der Webserver nutzt GZip zur komprimierten Übertragung der Webseite (HTML).
Performance
(Wenig wichtig)
Die Antwortzeit der HTML-Seite ist mit 1,01 Sekunden sehr langsam. Ein angepeiltes Ziel sollten 0,4 Sekunden sein. Suchmaschinen-Crawler können sonst Inhalte nicht so schnell aufnehmen und auch Besucher erwarten eine schnelle Webseite.
Die Dateigröße des HTML-Dokuments ist mit 221 kB in Ordnung.

HTTP-Header

NameWert
servernginx
dateSun, 14 Jul 2024 05:25:10 GMT
content-typetext/html; charset=UTF-8
varyAccept-Encoding
x-cache-enabledTrue
link<https://www.oncozine.com/wp-json/>; rel="https://api.w.org/", <https://www.oncozine.com/wp-json/wp/v2/pages/6893>; rel="alternate"; type="application/json", <https://www.oncozine.com/>; rel=shortlink
x-httpd1
x-cdn-call
content-encodinggzip
x-sg-cdn1
x-proxy-cacheHIT
host-header8441280b0c35cbc1147f8ba998a563a7
statuscode200
http_versionHTTP/2

Externe Faktoren

Blacklists
(Nice to have)
Die Seite wird nicht als "nur für Erwachsene" eingestuft.
Die Seite ist exzellent von anderen Webseiten verlinkt.
Die Seite hat Backlinks von 333 verweisenden Domains.
Die Seite hat insgesamt 1.075 Backlinks.
Die Seite hat Backlinks von 260 verschiedenen IP Adressen.
Verbreitung bei Facebook
(Wenig wichtig)
Die Seite hat 0 Shares und Kommentare auf Facebook.

Links von Wikipedia

Es wurden keine Links von Wikipedia gefunden.

Robots.txt

# START WPFORMS BLOCK
# ---------------------------
User-agent: *
Disallow: /wp-content/uploads/wpforms/
# ---------------------------
# END WPFORMS BLOCK

# START YOAST BLOCK
# ---------------------------
User-agent: *
Disallow:

Sitemap: https://www.oncozine.com/sitemap_index.xml
# ---------------------------
# END YOAST BLOCK

Ähnliche Seiten

Suchvorschau

www.oncozine.com
Home - Onco'Zine - A part of the Oncology and Hematology News ...
Onco'Zine is part of the Oncology and Hematology News Network that has been created to better inform physicians treating patients with cancer

Wichtigste Suchbegriffe

Folgende Keywords wurden erkannt. Überprüfe die Optimierung dieser Keywords für Deine Seite.

KeywordErgebnisPrüfen
Onco95%Check
Onco Zine94%Check
Zine91%Check
Oncology80%Check
Oncology Network78%Check
Network76%Check
Onco Zine Brief75%Check
Oncology Hematology69%Check
News Network69%Check
Hematology News Network65%Check
Weitere Keywords anzeigen

Analysiere jetzt kostenlos bis zu 1.000 Unterseiten von oncozine.com!

Kostenlos Testen
Die Nutzung des Basis Accounts ist zeitlich unbegrenzt möglich

Cookie Einstellungen

Wir verwenden Cookies, damit unsere Website funktioniert und auch für Analyse- und Werbezwecke. Du kannst optionale Cookies selbstverständlich auch deaktivieren, siehe die folgenden Links für weitere Informationen.

Impressum | Datenschutz

Diese Cookies werden für grundlegende Websitefunktionen benötigt.

Damit wir besser verstehen, wie Besucher unsere Website nutzen.

Damit wir für Dich passgenaue Angebote bereitstellen können.